{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:58:03Z","timestamp":1773982683330,"version":"3.50.1"},"reference-count":28,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9678","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T11:18:30Z","timestamp":1541675910000},"source":"Crossref","is-referenced-by-count":3,"title":["Diprophylline inhibits non\u2011small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway"],"prefix":"10.3892","author":[{"given":"Hong\u2011Ying","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun\u2011Hui","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Oncology, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu\u2011Bao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Xuzhou Cancer Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"key20200714084955_b1-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000485012","article-title":"Musashi1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Akt signaling pathway","volume":"44","author":"Lang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key20200714084955_b2-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4065\/83.5.584","article-title":"Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clinic Proc"},{"key":"key20200714084955_b3-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.seminoncol.2013.12.008","article-title":"Genes and pathology of non-small cell lung carcinoma","volume":"41","author":"Sakashita","year":"2014","journal-title":"Semin Oncol"},{"key":"key20200714084955_b4-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"177","DOI":"10.14694\/EdBook_AM.2014.34.177","article-title":"50 years of progress in the systemic therapy of non-small cell lung cancer","volume":"34","author":"Wakelee","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20200714084955_b5-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/PPO.0000000000000141","article-title":"Chemotherapy for advanced-stage non-small cell lung cancer","volume":"21","author":"Du","year":"2015","journal-title":"Cancer J"},{"key":"key20200714084955_b6-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2169\/internalmedicine.54.4394","article-title":"Feasibility of rebiopsy in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors","volume":"54","author":"Hasegawa","year":"2015","journal-title":"Intern Med"},{"key":"key20200714084955_b7-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3390\/nu5104159","article-title":"Health benefits of methylxanthines in cacao and chocolate","volume":"5","author":"Franco","year":"2013","journal-title":"Nutrients"},{"key":"key20200714084955_b8-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-642-13443-2_9","article-title":"Methylxanthines, seizures, and excitotoxicity","author":"Boison","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"key20200714084955_b9-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5005\/jp-journals-10024-1221","article-title":"Effect of methylxanthines (coffee\/tea consumers) on oral precancer and oral cancer patients with smoking and smokeless tobacco habits","volume":"13","author":"Zubairy","year":"2012","journal-title":"J Contemp Dent Pract"},{"key":"key20200714084955_b10-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-011-0929-8","article-title":"Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells","volume":"358","author":"Goel","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"key20200714084955_b11-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.lungcan.2011.03.017","article-title":"Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro","volume":"74","author":"Lange","year":"2011","journal-title":"Lung Cancer"},{"key":"key20200714084955_b12-ol-0-0-9678","first-page":"16","article-title":"Differential effect of selected methylxanthine derivatives on radiosensitization of lung carcinoma cells","volume":"28","author":"Malki","year":"2006","journal-title":"Exp Oncol"},{"key":"key20200714084955_b13-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4161\/cbt.28018","article-title":"Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase\/Akt pathway","volume":"15","author":"Edling","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"key20200714084955_b14-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00008390-199804000-00005","article-title":"Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation","volume":"8","author":"Lentini","year":"1998","journal-title":"Melanoma Res"},{"key":"key20200714084955_b15-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF03190144","article-title":"Absorption of intra-bronchial diprophylline-methodology and preliminary results","volume":"17","author":"Morais","year":"1992","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"key20200714084955_b16-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40360-017-0179-9","article-title":"Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos","volume":"18","author":"Basnet","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"key20200714084955_b17-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000210963","article-title":"Xanthines inhibit 3T3 fibroblast proliferation","volume":"4","author":"Levi-Schaffer","year":"1991","journal-title":"Skin Pharmacol"},{"key":"key20200714084955_b18-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway","volume":"142","author":"Polivka","year":"2014","journal-title":"Pharmacol Ther"},{"key":"key20200714084955_b19-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: An updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann Med"},{"key":"key20200714084955_b20-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3748\/wjg.v20.i5.1127","article-title":"Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714084955_b21-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40272-013-0063-z","article-title":"Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity","volume":"16","author":"Schoen","year":"2014","journal-title":"Paediatr Drugs"},{"key":"key20200714084955_b22-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation","volume":"12","author":"Stork","year":"2002","journal-title":"Trends Cell Biol"},{"key":"key20200714084955_b23-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1590\/S0100-879X2012007500087","article-title":"Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation","volume":"45","author":"Ionta","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"key20200714084955_b24-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4196\/kjpp.2014.18.1.47","article-title":"Characteristics of diprophylline-induced bidirectional modulation on rat jejunal contractility","volume":"18","author":"Liu","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"key20200714084955_b25-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.mehy.2013.03.029","article-title":"Targetting cancer with Ru(III\/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer","volume":"80","author":"Koiri","year":"2013","journal-title":"Med Hypotheses"},{"key":"key20200714084955_b26-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.7150\/jca.21783","article-title":"Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer","volume":"8","author":"Domvri","year":"2017","journal-title":"J Cancer"},{"key":"key20200714084955_b27-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"e30427","DOI":"10.1371\/journal.pone.0030427","article-title":"Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): New insights on the role of phosphatydil-inositol-3 kinase","volume":"7","author":"Scrima","year":"2012","journal-title":"PLoS One"},{"key":"key20200714084955_b28-ol-0-0-9678","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:45:20Z","timestamp":1594719920000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":28,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9678","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]}}}